Advertisement

Topics

Intec Pharma to Participate in the 29th Annual Roth Conference

08:54 EST 10 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Intec Pharma Ltd. (Nasdaq: NTEC), a late stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces that Company management will participate at the 29th ...

Other Sources for this Article

Intec Pharma
Zeev Weiss, +972-(2)586-4657
Chief Executive Officer
zeev@intecpharma.com
or
LHA
Anne Marie Fields, 212-838-3777
Senior Vice President
afields@lhai.com

NEXT ARTICLE

More From BioPortfolio on "Intec Pharma to Participate in the 29th Annual Roth Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...